[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ejection-fraction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ejection-fraction":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100571776",false,"NCT06724653","Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial","HFrecEF","Inclusion Criteria:\n\n* initial echocardiogram ejection fraction less than 40%\n* follow up echocardiogram ejection fraction over 50% and LVEDD index normal range\n* NTprobnp criteria\n\n  1. eGFR ≥60 ; less 440\n  2. eGFR 45-59: less 980\n  3. eGFR 30-44; less 1220\n  4. eGFR \\\u003C 30 : less 5300\n  5. in HD; no criteria for NTproBNP\n* on more than 3 heart failure medication ( RAS blocker, beta blocker, mineral corticoid receptor antagonist, SGLT 2 inhibitor)\n\nExclusion Criteria:\n\n1. under age 18 year\n2. uncontrolled BP ( over 150\u002F90)\n3. coronary revascularization within 6 months\n4. significant valve disease\n5. arrhythmia requiring rate control\n6. CKD with albuminuria ( over 30mg\u002Fg)\n7. Pregnancy","ALL","18 Years",{"count":18,"type":19},150,"ESTIMATED","INTERVENTIONAL",[22],"NA","Study start date is on Nov 27th 2024.\n\nA patient with an initial ejection fraction (EF) of less than 40%, whose follow-up shows an improvement to an EF of 50% or higher, along with the left ventricular end-diastolic diameter returning to the normal range and taking 3 more heart failure medication randomed to drug tapering group ( RAS blocker or beta blocker) or continuing medication group.",[25,26,27],"Heart Failure","Ejection Fraction","Recovery of Function",[29,30],"heart failure with recovered ejection fraction","Tapering","RECRUITING","2026-03-23",{"date":34,"type":35},"2026-03-27","ACTUAL",{"date":37,"type":35},"2025-03-06",{"date":39,"type":19},"2027-11-26",{"name":41,"class":42},"Chungnam National University Hospital","OTHER",2,""]